Senior / Manager, Clinical Business Operations

The Opportunity :

As Manager / Senior Manager, Clinical Business Operations, you will be responsible for the execution of clinical site contracts and budgets to support the achievement of clinical trial study goals. You will coordinate activities across internal stakeholders (Legal, Clinical Operations), CROs, and study sites to effectively deliver negotiated site agreements that balance risk, budget, and speed. This role will report into the Associate Director, Clinical Business Operations.

Your Role :

• Manage the successful negotiation and ongoing management of clinical trial agreements with investigative sites, including providing status updates to key stakeholders during internal and external meetings as needed.
• Serve as main point of contact for US site negotiations and collaborate cross-functionally with CROs on ex-US site negotiations; oversee development and approval of investigator site budgets and associated negotiation parameters. Ensure cross-trial consistency in country-level site budget targets and parameters.
• Maintain oversight of CROs to ensure compliant and timely execution of site contracts and budgets.
• Leverage use of internal and CRO provided Investigator Grants reference data and available Fair Market Value (FMV) benchmarking tools to establish and negotiate site budgets.
• Proactively identify site contract / budget related issues or risks and escalate to AD, CBO and other functions (Legal, Clinical Operations) as needed to prevent delays in site activation timelines.
• Maintain site contract and budget records for all Relay Tx studies in designated study SharePoint folders for completeness and inspection readiness.
• Track and benchmark contract cycle times, adherence to site budgets, and negotiation consistency across Relay Tx studies.
• Supports negotiation of other vendor agreements or investigator-sponsored trials.

Your Background :

About Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, we aim to effectively drug protein targets that have previously been intractable, with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Our Dynamo platform integrates an array of leading-edge experimental and computational approaches to provide a differentiated understanding of protein structure and motion to drug these targets. We have built a world-class team of leading experts from each of these disciplines, and they are driven by a deep collaboration at every step of our drug discovery process.

Our team is equal parts fearless and relentless, with a shared passion for working collaboratively in intellectually stimulating environments. If you're excited by the challenge of putting protein motion at the heart of drug discovery and passionate about making a difference in the lives of patients, join us!